Jinhe Biotechnology(SZ:002688) Xin Lang Cai Jing·2025-09-09 04:18Company Overview - Jinhe Biology Technology Co., Ltd. is located in Inner Mongolia and was established on March 14, 1990, with its listing date on July 13, 2012 [2] - The company specializes in the production, sales, research, and service of animal health products [2] - The revenue composition includes veterinary chemical drugs (61.83%), starch and related products (19.76%), veterinary vaccines (11.12%), environmental services (4.97%), and other products (2.15%) [2] Financial Performance - For the first half of 2025, Jinhe Biology achieved operating revenue of 1.39 billion yuan, a year-on-year increase of 30.45% [2] - The net profit attributable to the parent company was 138 million yuan, reflecting a year-on-year growth of 51.52% [2] - The company has distributed a total of 877 million yuan in dividends since its A-share listing, with 227 million yuan in the last three years [2] Stock Performance - As of September 9, Jinhe Biology's stock price was 7.00 yuan per share, with a market capitalization of 5.40 billion yuan [1] - The stock has increased by 60.07% year-to-date, but has seen a decline of 2.78% over the last five trading days and 8.97% over the last twenty days [1] - The company has appeared on the trading leaderboard six times this year, with the most recent appearance on April 16, where it recorded a net buy of -28.30 million yuan [1] Shareholder Information - As of June 30, 2025, the number of shareholders increased to 64,500, up by 104.38% from the previous period [2] - The average number of circulating shares per shareholder decreased by 51.07% to 11,547 shares [2] - Among the top ten circulating shareholders, Guotai CSI Livestock Breeding ETF is the third-largest shareholder, holding 7.66 million shares as a new investor [2]